TNF receptor-associated factor 1 is a positive regulator of the NF-κB alternative pathway

Molecular Immunology

Volumn 46, Issue 16, 2009, Pages 3278-3282

  Lavorgna, Alfonso ^a   De Filippi, Rosaria ^a   Formisano, Silvestro ^a   Leonardi, Antonio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

BAFF R; NF B; TRAF1

Indexed keywords

B CELL ACTIVATING FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P100; PROTEIN P52; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; MYELOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

B-CELL ACTIVATION FACTOR RECEPTOR; CELL LINE, TUMOR; GENE EXPRESSION; HODGKIN DISEASE; HUMANS; NF-KAPPA B; PROTEIN STABILITY; PROTEIN-SERINE-THREONINE KINASES; TNF RECEPTOR-ASSOCIATED FACTOR 1; TNF RECEPTOR-ASSOCIATED FACTOR 3; ZINC FINGERS;

EID: 70349459622     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.07.029     Document Type: Article

References (25)

1. Annunziata C.M., Davis R.E., Demchenko Y., Bellamy W., Gabrea A., Zhan F., Lenz G., Hanamura I., Wright G., Xiao W., Dave S., Hurt E.M., Tan B., Zhao H., Stephens O., Santra M., Williams D.R., Dang L., Barlogie B., Shaughnessy Jr. J.D., Kuehl W.M., and Staudt L.M. Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 12 2 (2007) 115-130
2. Bonizzi G., Bebien M., Otero D.C., Johnson-Vroom K.E., Cao Y., Vu D., Jegga A.G., Aronow B.J., Ghosh G., Rickert R.C., and Karin M. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J. 23 21 (2004) 4202-4210
3. Bradley J.R., and Pober J.S. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20 (2001) 6482-6491
4. Devin A., Cook A., Lin Y., Rodriguez Y., Kelliher M., and Liu Z. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12 (2000) 419-429
5. Habelhah H., Takahashi S., Cho S.G., Kadoya T., Watanabe T., and Ronai Z. Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB. EMBO J. 23 (2004) 322-332
6. Hacker H., and Karin M. Regulation and function of IKK and IKK related-kinases. Sci. STKE (2006) re13
7. Hayden M.S., West A.P., and Ghosh S. NF-κB and the immune response. Oncogene 25 (2006) 6758-6780
8. Hauer J., Puschner S., Ramakrishnan P., Simon U., Bongers M., Federle C., and Engelmann H. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 2874-2879
9. Izban K.F., Ergin M., Martinez R.L., and Alkan S. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells. Mod. Pathol. 13 12 (2000) 1324-1331
10. Kanzler H., Hansmann M.L., Kapp U., Wolf J., Diehl V., Rajewsky K., and Küppers R. Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin's lymphoma patient. Blood 87 8 (1996) 3429-3436
11. Keats J.J., Fonseca R., Chesi M., Schop R., Baker A., Chng W.J., Van Wier S., Tiedemann R., Shi C.X., Sebag M., Braggio E., Henry T., Zhu Y.X., Fogle H., Price-Troska T., Ahmann G., Mancini C., Brents L.A., Kumar S., Greipp P., Dispenzieri A., Bryant B., Mulligan G., Bruhn L., Barrett M., Valdez R., Trent J., Stewart A.K., Carpten J., and Bergsagel P.L. Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma. Cancer Cell. 12 2 (2007) 131-144
12. Lamothe B., Campos A.D., Webster W.K., Gopinathan A., Hur L., and Darnay B.G. The RING domain and first zinc finger domain of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL. J. Biol. Chem. 283 36 (2008) 24871-24880
13. Leonardi A., Ellinger-Ziegelbauer H., Franzoso G., Brown K., and Siebenlist U. Functional interaction of filamin and TNF-receptor associated factor 2 (TRAF2). J. Biol. Chem. 275 (2000) 271-278
14. Liao G., Zhang M., Harhaj E.W., and Sun S.C. Regulation of the NF-κB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 279 (2004) 26243-26250
15. Sabbagh L., Srokowski C.C., Pulle G., Snell L.M., Sedgmen B.J., Liu Y., Tsitsikov E.N., and Watts T.H. A critical role for TNF receptor-associated factor 1 and Bim down-regulation in CD8 memory T cell survival. Proc. Natl. Acad. Sci. U.S.A. 103 49 (2006) 18703-18708
16. Scheidereit C. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25 (2006) 6685-6705
17. Tsitsikov E.N., Laouini D., Dunn I.F., Sannikova T.Y., Davidson L., Alt F.W., and Geha R.S. TRAF1 is a negative regulator of TNF signaling: enhanced TNF signaling in TRAF1-deficient mice. Immunity 15 (2001) 647-657
18. Vallabhapurapu S., Matsuzawa A., Zhang W., Tseng P.H., Keats J.J., Wang H., Vignali D., Bergsagel P.L., and Karin M. Non redundant and complementary function of TRAF2 and TRAF3 in a ubiquitation cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat. Immunol. 9 12 (2008) 1364-1370
19. Vallabhapurapu S., and Karin M. Regulation and function of NF-kappaB transcription factor in the immune system. Ann. Rev. Immunol. 27 (2009) 693-733
20. Wajant H., Pfizenmaier K., and Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 10 (2003) 45-65
21. Wicovsky A., Henkler F., Salzmann S., Scheurich P., Kneitz C., and Wajant H. Tumor necrosis factor receptor-associated factor-1 enhances proinflammatory TNF receptor-2 signaling and modifies TNFR1-TNFR2 cooperation. Oncogene 28 15 (2009) 1769-1781
22. Wolf J., Kapp U., Bohlen H., Kornacker M., Schoch C., Stahl B., Mücke S., von Kalle C., Fonatsch C., Schaefer H.E., Hansmann M.L., and Diehl V. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. Blood 87 8 (1996) 3418-3428
23. Yamamoto M., Okamoto T., Takeda K., Sato S., Sanjo H., Uematsu S., Saitoh T., Yamamoto N., Sakurai H., Ishii K.J., Yamaoka S., Kawai T., Matsuura Y., Takeuchi O., and Akira S. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat. Immunol. 7 (2006) 962-970
24. Zapata J.M., Krajewska M., Krajewski S., Kitada S., Welsh K., Monks A., McCloskey N., Gordon J., Kipps T., Goscoyne R.D., Shabaik A., and Reed J.C. TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies. J. Immunol. 165 (2000) 5084-5096
25. Zarnegar B.J., Wang Y., Mahoney D.J., Dempsey P.W., Cheung H.H., He J., Shiba T., Yang X., Yeh W., Mak T.W., Korneluk R.G., and Cheng G. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors c-IAP1-2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol. 9 12 (2008) 1371-1378